🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/04/2007 | 26,94 | 27,27 | 26,94 | 27,15 | +0,41% | 1,21% | 1.162.200 |
| 17/04/2007 | 27,08 | 27,22 | 26,82 | 27,04 | -0,26% | 1,50% | 1.208.800 |
| 16/04/2007 | 26,96 | 27,23 | 26,91 | 27,11 | +0,61% | 1,17% | 604.600 |
| 13/04/2007 | 27,05 | 27,10 | 26,62 | 26,95 | -0,52% | 1,77% | 1.051.400 |
| 12/04/2007 | 26,17 | 27,17 | 26,06 | 27,09 | +3,50% | 4,24% | 2.247.400 |
| 11/04/2007 | 26,10 | 26,25 | 25,88 | 26,17 | +0,60% | 1,40% | 791.000 |
| 10/04/2007 | 26,17 | 26,38 | 25,93 | 26,02 | -0,97% | 1,70% | 1.235.000 |
| 09/04/2007 | 26,36 | 26,53 | 26,17 | 26,27 | -0,40% | 1,37% | 1.520.000 |
| 05/04/2007 | 26,42 | 26,64 | 26,35 | 26,38 | -0,47% | 1,10% | 1.066.600 |
| 04/04/2007 | 26,71 | 26,76 | 26,39 | 26,50 | -0,93% | 1,40% | 1.365.800 |
| 03/04/2007 | 26,78 | 27,01 | 26,73 | 26,75 | +0,04% | 1,05% | 1.222.400 |
| 02/04/2007 | 26,89 | 26,99 | 26,54 | 26,74 | -0,56% | 1,65% | 1.100.000 |
| 30/03/2007 | 26,81 | 27,00 | 26,74 | 26,89 | +0,06% | 0,99% | 843.000 |
| 29/03/2007 | 27,32 | 27,42 | 26,53 | 26,88 | -1,47% | 3,26% | 1.660.200 |
| 28/03/2007 | 27,40 | 27,50 | 27,16 | 27,28 | -0,73% | 1,26% | 678.600 |
| 27/03/2007 | 27,71 | 27,75 | 27,33 | 27,48 | -1,13% | 1,52% | 840.600 |
| 26/03/2007 | 28,37 | 28,52 | 27,64 | 27,79 | -1,63% | 3,12% | 1.935.400 |
| 23/03/2007 | 28,02 | 28,31 | 27,88 | 28,25 | +1,11% | 1,55% | 938.000 |
| 22/03/2007 | 28,24 | 28,24 | 27,80 | 27,94 | -0,71% | 1,58% | 1.678.000 |
| 21/03/2007 | 28,44 | 28,44 | 27,95 | 28,14 | -0,83% | 1,74% | 1.663.000 |
| 20/03/2007 | 28,38 | 28,43 | 28,08 | 28,38 | -0,37% | 1,23% | 1.198.600 |
| 19/03/2007 | 27,90 | 28,56 | 27,76 | 28,48 | +3,02% | 2,87% | 1.689.000 |
| 16/03/2007 | 27,97 | 28,09 | 27,56 | 27,65 | -1,16% | 1,90% | 950.200 |
| 15/03/2007 | 27,98 | 28,40 | 27,78 | 27,97 | -0,59% | 2,23% | 1.197.400 |
| 14/03/2007 | 27,17 | 28,30 | 27,17 | 28,14 | +3,34% | 4,16% | 2.171.600 |
| 13/03/2007 | 27,05 | 27,64 | 27,03 | 27,23 | -0,06% | 2,27% | 1.734.200 |
| 12/03/2007 | 26,92 | 27,47 | 26,92 | 27,24 | +1,02% | 2,04% | 1.044.200 |
| 09/03/2007 | 26,99 | 27,25 | 26,77 | 26,97 | +0,78% | 1,78% | 1.199.200 |
| 08/03/2007 | 27,05 | 27,33 | 26,64 | 26,76 | -0,76% | 2,55% | 1.212.000 |
| 07/03/2007 | 27,18 | 27,26 | 26,77 | 26,96 | -0,96% | 1,80% | 2.379.400 |